McGill Univeristy; Douglas Mental Health University Institute; Neurological and Psychiatric

Verdun, Quebec H4H 1R3

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab — Completed
• A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) — Completed
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed